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African trypanosomiasis is the collective name for awide
variety of trypanosome infections that affect humans
and livestock. In recent years, experimental mice infec-
tion models have provided new insights into both
human and animal trypanosomiasis. Mouse models
seem to be a valuable and versatile tool in trypanoso-
miasis-associated pathology and immunology research
and highlight the variety shown by African trypanoso-
miases. Indeed, inbred mouse strains have enabled the
study of genetic determinants of susceptibility and of
the roles of anti-parasite antibodies, inflammatory
mediators and anti-inflammatory mediators for each
trypanosome species. Remarkable advances relating
to the encephalitic stage of sleeping sickness have also
been achieved thanks to murine models. The different
contributions of murine models to the African trypano-
somiases knowledge are presented here. Future search
directions are finally proposed, with respect to mouse
model opportunities and limitations.
‘African trypanosomiasis’: not a single disease
‘African trypanosomiasis’ is a parasitic condition that
affects both humans and livestock in Sub-Saharan Africa
and represents a vital and economic threat. The term
‘African trypanosomiasis’ actually encompasses different
types of diseases and includes infections by a broad range
of trypanosome species. Indeed, parasites belonging to the
Trypanozoon subgenus – including Trypanosoma brucei
rhodesiense and Trypanosoma brucei gambiense (the cau-
sative agents of human African trypanosomiasis, or HAT),
Trypanosoma brucei brucei, Trypanosoma equiperdum and
Trypanosoma evansi (Box 1) – are characterized by their
ability to invade the extravascular compartment and to
cause the development of neurological disease. In particu-
lar, HAT is characterized by two different disease stages.
The early stage is characterized by the confined presence of
parasites in the blood and lymphoid fluids, whereas the
second stage is determined by the entrance of the parasite
into the central nervous system (CNS), by breaking
through the blood–brain barrier (BBB). By contrast,
Trypanosoma congolense (Nanomonas) infections are
characterized by a strictly intravascular distribution of
the parasite. Trypanosoma vivax (Dutonella) infections
constitute a third type of host–pathogen interaction that
is poorly characterized.
All African trypanosomes use antigenic variation of
their surface antigens as the main defence system against
the immune system of their mammalian host; this enables
a continuous escape from the host anti-parasite antibody
response [1]. The presence of the trypanosome variant
surface glycoprotein (VSG) coat,moreover, hampers immu-
nization against the trypanosomes and leaves chemother-
apy as the only disease-control method for humans. With
respect to animal trypanosomiasis, rearing trypanotoler-
ant cattle might be considered as a sustainable alternative
for animal production in glossina-infected areas, where the
continuous long-term treatment of animals causes a risk of
the induction of drug resistance.
Despite their biological differences, all African trypano-
somes cause common pathology signs such as immunosup-
pression, cachexia and anaemia, for which the underlying
mechanisms can vary. Ethical and practical constraints in
investigating trypanosomiasis-associated pathology under
natural conditions have led, in recent years, to the de-
velopment of severalmousemodels. Being highly versatile,
the inbred mouse model is a valuable tool in pathology
research because it enables genetic studies of particular
phenotypic differences between mouse strains and patho-
genesis studies by testing the impact on disease outcome of
particular treatments on uniform genetic backgrounds. In
addition, genotypic alterations (gene knockout or trans-
genic strains) are nowwidely used and give this approach a
new dimension.
Inbred mice: a tool to dissect natural variations in
trypanosomiasis susceptibility
The most frequently used mouse strains for comparison of
susceptibility to trypanosomiasis are C57Bl/6, BALB/c and
C3H/He. Interestingly, despite all possible pitfalls, the
susceptibility ranking of these strains is stable among
different trypanosome species; C57Bl/6 mice generally
show longer survival and better parasite control than
BALB/c and C3H/He mice [2–8]. However, remarkable
differences appear and deserve some attention (Figures
1,2). So far, not a single inbred mouse strain is available
that can be classified as resistant to trypanosomes (Box 2).
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In T. congolense infection, BALB/c and CBA mice show
themost susceptible phenotypes and succumb to infections
less than ten days after infection [2]. By contrast, C57Bl/6
mice T. congolense infections have been reported to last for
over two or four months [2,3]. Survival times below or
around 25 days are reported for infections in C3H, CFLP
and A/J mice [2,3].
In T.b. rhodesiense infections, C3H/He, DBA/1, DBA/2
and BALB/c mice are described as the most susceptible
strains, surviving less than or around 20 days, whereas an
intermediate phenotype with survival times between 20
and 30 days is presented by the A/J mouse strain [4–6].
C57Bl/6 mice also exhibit prolonged survival [4–6]. Similar
rankings for C3H/He and C57Bl/6 are obtained in related
T.b. brucei infections [2,7]. The CFLP strain has the long-
est survival for T.b. brucei infections, which greatly differs
from T. congolense rankings [2]. Interestingly, although
the CBA mouse strain was reported to have an intermedi-
ate survival phenotype in experimental T.b. rhodesiense
infections [4–6], it exhibits prolonged survival in case of T.
brucei infections, similar to [2] or even longer than C57Bl
[7]. These results indicate that besides the genetic back-
ground of the host, the precise genetic parasite background
and the interaction between the two will also be crucial in
determining the lifespan of the infected host. In the same
context, it is important to mention that BALB/c mice
exhibit prolonged survival in T.b. gambiense infection, in
contrast to T.b. rhodesiense and T.b. brucei infections,
which possibly indicates differences in pathogenesis be-
tween the human-infecting subspecies [9].
Susceptibility ranking in T. evansi infections has been
hampered by the worldwide distribution of this parasite
(Box 1) and, thereby, the wide range of parasites used by
laboratories. In one study, different rankings resulted from
infections with different South American parasite strains
[8]. For the six trypanosome strains tested, four presented
the classical ranking with C3H/He and BALB/c showing
the shortest survival and C57Bl/6 the longest. One strain
showed inverse phenotypic ranking with C57Bl/6 being
more susceptible than C3H/He and BALB/c (Figure 2).
Box 1. ‘African’ trypanosomiasis across the world
Trypanosoma brucei rhodesiense and Trypanosoma brucei gam-
biense are the causal agents of sleeping sickness and are the only
trypanosomes known so far to be directly pathogenic for healthy
humans on the African continent. By contrast, whereas Trypanoso-
ma congolense and Trypanosoma vivax are the major agents of
Sub-Saharan animal trypanosomiasis, Trypanosoma brucei brucei
is also a causal agent. All T. brucei species and T. congolense
parasites are haemoflagellates that are transmitted by Glossina spp.
and are, thus, restricted to the distribution area of their vector.
However, three other trypanosome species, which are present on
the African continent and beyond, are glossina-independent be-
cause they are adapted to different transmission pathways. Hence,
they can be found outside the tsetse belt. T. vivax can be
mechanically transmitted and is also present in South America.
Similarly, Trypanosoma equiperdum, the agent of dourine in
horses, is sexually transmitted and is present in Africa, Europe
and Asia. T. evansi is mechanically transmitted by haematopha-
geous flies, such as tabanids, and is widespread across the Sahel
and North Africa, Asia and South America, affecting economically
important species such as camels, horses and buffaloes. It is
interesting to note that in recent years, several cases of human
Trypanosoma evansi infections have been reported in India, which
were attributed to a lack of apolipoprotein L-1 [64,65].
Figure 1. Survival rankings for ‘African trypanosomiasis’ among different mice strains. This figure illustrates the divergences among mice susceptibility rankings according
to the parasite species or strain used. The sex of tested animals is indicated next to the parasite species, when the information was available. Differences in ranking are
particularly striking when comparing CBA/CaJ and C57Bl/6 between T.b. rhodesiense and T. brucei or C57Bl, CBA and CFLP between T. brucei and T. congolense. Data
presented in this figure are from Refs [2,5–7].
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Genomics of trypanosomiasis susceptibility: can
genetic crossbreeding provide new answers?
Susceptibility patterns were first used to approach the
genetic determinants of murine trypanosomiasis control
through breeding schemes. Such breeding schemes involve
two mice strains presenting opposite phenotypes and con-
sists of successive crosses. In a first step, they allow the
description of the mode of inheritance of the studied phe-
notype (dominant, recessive, sex-linked or autosomal).
Then, through numerous recombinations produced inside
the genomes of each obtained individual, a phenotyping
procedure coupled to a genomic screening (microsatellites
or single nucleotide polymorphism) will enable the study of
correlations between phenotype and genotype, further
resulting in the detection of quantitative trait loci (QTL)
and their mapping.
In T. congolense infections, studies of [C57Bl/6xBALB/
c]-crosses indicated that the difference in survival time
observed between parental strains was accounted for by
three loci [Trypanosoma infection response-1 (Tir1), Tir2
and Tir3, mapped to chromosomes 17, 5 and 1, respect-
ively] [10,11]. Further analysis, using advanced intercross
lines (AIL) from [C57Bl/6xA/J] and [C57Bl/6xBALB/c]-
crosses confirmed these three loci and improved resolution
to a confidence interval of fewer than 20 cM [12]. The role of
two Tir1 candidate genes, tumor necrosis factor (TNF) and
heat shock protein 70.1 (HSP70.1), has been studied in T.
congolense-infected C57Bl/6 mice with deletions in the
relevant genes. Although no involvement of HSP70.1 in
survival was indicated [13], TNF-disrupted C57Bl/6 mice
showed a significantly shortened survival [14,15]. AIL-
analyses revealed a high degree of complexity of Tir3,
which is composed of three loci called ‘Tir3a’, ‘Tir3b’ and
‘Tir3c’. Marker-assisted introgression of the three loci from
a long-surviving donor strain (C57Bl/6) to a susceptible
recipient strain (A/J) successfully resulted in a survival-
effect transfer, close to the original mapping population
[16]. The cytokine interleukin-10 (IL-10) gene and the
Cypr2 locus, which is involved in the regulation of IL-10
synthesis, are candidates for the Tir3b locus [17].
However, early T. congolense studies described distinct
inheritance modes for survival and parasitaemia control
(autosomal dominant and recessive, respectively), thereby
indicating that they are independent, as also shown below
for T.b. rhodesiense [18,19]. Nevertheless, because these
studies do not use the same cross, no conclusion can be
drawn because this choice could greatly influence the
output [3]. Interestingly, sex-associated factors seemed
to confer an advantage in T. congolense control to females,
as confirmed by more recent studies [14,19].
In contrast to the T. congolense-obtained results
described above, the results provided by T. brucei models
are less conclusive. Infection with T.b. rhodesiense Lou-
Tat1 in F1 mice (a cross between B10.BR/SgSnJ and
C3HeB/FeJ) indicated that survival and parasitaemia con-
trol segregate as independent traits, with survival being
recessive and parasitaemia control being dominant [20].
These results confirmed an earlier radiation chimaera
study that showed independency between both traits
[21]. However, a third model, using [C57Bl/6xBALB/c]-
crosses infected by T.b. rhodesiense EATRO1886, showed
survival inherited as a dominant trait [4]. Similar to T.
congolense infections, females exhibited prolonged survival
to T.b. rhodesiense EATRO1886 infection [5]. X-linked
genes, however, did not account for this difference.
One consensus that comes out of using different
mouse models is the lack of effect of the major histocom-
patibility complex (MHC), MHC-linked genes or H-2 locus
in influencing susceptibility to African trypanosomiasis
[3,6,22].
Figure 2. Mice-survival rankings for different T. evansi strains. The survival of three classically used mice strains (BALB/c, C3H/He and C57B1/6) after infection with different
T. evansi isolates is shown. T. evansi strains are named after the animal species from which they were isolated. Particularly striking are the unusual relative susceptibility of
C57Bl/6 to infection by strain ‘coati1’ and the remarkable relative resistance of BALB/c to infection by strain ‘horse2’. Data presented in this figure are from Ref. [8].
Box 2. Trypanotolerance in mice
In the past, several authors have used the term ‘resistance’ to
indicate mouse strains that develop slowly progressing infections.
However, attention should be paid to the use of words such as
‘resistance’ versus ‘tolerance’. Here, ‘tolerance’ is considered to be
the ability to limit the pathological consequences of infection, and
‘resistance’ is considered to be the ability to impede the entry or
multiplication of an infectious agent, or the complete elimination of
an infectious agent from the host. Hence, the term ‘resistance’ does
not apply to murine models for T. brucei, T. congolense, T. evansi or
T. vivax because, to date, no mouse strain has been identified that is
not killed by any of these parasites. To date, the ranking of mouse
strains for susceptibility to trypanosomiasis is made through the
follow-up of parasitaemia and survival. However, it should be kept
in mind that survival is an imprecise parameter because the cause of
death can vary among mouse strains, trypanosome species and
disease stages. Indeed, trypanosomiasis-associated death in experi-
mental murine models can result from systemic inflammatory
response syndrome (SIRS) [7,23,26], renal failure (possibly linked
to immune-complex formation) [8], anaemia or CNS invasion. In
addition, immunodepression could make a trypanosome-infected
host susceptible to opportunistic infections in situations where mice
are exposed to such agents.
Review Trends in Parasitology Vol.24 No.9
413
Author's personal copy
In conclusion, breeding schemes were successful at
providing important clues. As the most conclusive studies
studying survival have been done in T. congolense, new
responses can be expected from the use of different trypa-
nosomes, phenotypes and parental strains. A renewed
interest in the long quest to QTL mapping is, thus, needed
because this approach has the great advantage of enabling
the discovery of unsuspected genes because it is purely
phenotype-driven.
Immune responses and trypanosomiasis susceptibility:
new answers from the use of knockout mice
African trypanosomes evade the host immune response
through mechanisms that include VSG variation and host
immune modulation. The modifications of cytokines, lym-
phokines and other immune effectors during the course of
infection, and their relative role in susceptibility to trypa-
nosomiasis, have been studied in several mouse models. So
far, mainly anti-cytokine antibody treatment and knockout
mouse models have been used [7,13–15,23–26]. In particu-
lar, the use of knockoutmice for in vivo studies has recently
given trypanosome research a new dimension because
antibody-mediated neutralization of immune factors has
not always been completely efficient.
Parasite control through anti-VSG antibodies: an
operating system that remains to be functionally
elucidated
The main mechanism that is believed to mediate African
trypanosomiasis control in a mammalian host is the con-
tinuous interplay between the parasite’s VSG and host
antibodies. Although this interaction is presently con-
sidered to be a textbook example, the functional role of
the antibodies remains a point of debate in mouse and
bovine models [27].
Recently, the role of antibodies has been addressed in
experimental models using both B-cell-deficient and
immunoglobulin M (IgM)-deficient mice infected with T.
congolense [28] and T. evansi parasites [29]. In T. congo-
lense, only IgGs were crucial for parasitaemia control [28].
By contrast, in T. evansi infections, the main anti-VSG
antibody role was executed by the infection-induced IgM
antibodies. Interestingly, although the trypanosome-clear-
ing activity of antibodies is most likely due to antibody-
mediated phagocytosis of opsonized parasites by macro-
phages, including Kupffer cells [30], there is no experimen-
tal data pinpointing the macrophage receptor involved in
this process.
A role for complement-mediated lysis in parasite clear-
ance has been proposed but could not be confirmed because
T. evansi-infected complement (C5)-deficient AKR mice
control successive parasitaemia waves as efficiently as
complement-competent strains [29]. In T. brucei infection,
although C3 complement factor could aid in hepatic para-
site phagocytosis during vaccine-induced parasite clear-
ance, no in vivo contribution of complement-mediated lysis
to parasite control could be ascertained [31].
TNF and nitric oxide: the double agents
Besides antibodies and non-immune effector mechanisms,
various immunoregulatory and effector molecules could be
involved in trypanosome growth control. In trypanosomia-
sis, the first cytokine that was described was TNF [32,33].
Analysing the possible role of TNF in trypanosomiasis
control has confirmed the notion described above that
‘African trypanosomiasis’ as such is virtually impossible
to describe as a single disease. Hence, the review of the
data available to date on the role of TNF in trypanoso-
miasis is presented here in a species-specific manner. The
same approach is taken for nitric oxide (NO), an inflam-
matory mediator that is closely linked to TNF from the
point of parasitemia control.
In T. congolense infections, TNF-deficient mice present
severely shortened survival times and fail to control the
first parasitaemia peak [14,15,34]. A recent study invol-
ving iNOS/ (inducible nitric oxide synthase-deficient),
TNF/, TNF-R(receptor)1/ and TNF-R2/ mice con-
firmed that TNF and NO cooperate in controlling T. con-
golense [15]. Because T. congolense elimination has been
proposed to occur mainly in the liver [30], this study
focused on TNF-R1 (CD120a/p55) signal transduction
and its role in liver iNOS activation. TNF-R1 signalling
was necessary for optimal NO production, NO aided in
parasite killing, and the correct anti-VSG antibody induc-
tion pathway was activated in the host. Interestingly, NO
secretion depended on the Ig isotypes produced; IgG2a
induced NO levels that were two- to ninefold higher than
those induced by IgM [35].
InT. brucei infections, the role of TNF seemsmuchmore
complicated because of its possible direct effect on parasite
proliferation and its involvement in T. brucei-associated
anaemia.
TNF induction and the responsible parasite factor
(VSG-glycosylphosphatidylinositol anchor) are fully
characterized andMyD88 (myeloid differentiation primary
response gene 88) dependent [36,37]. During infection,
TNF has been reported to be protective in cases in which
it exhibits static and lytic effects on the T. brucei parasites
[38–40]. In accordance, TNF-deficient mice showed
increased parasitaemia in both T.b. brucei and T.b. rho-
desiense infection [7,34,41,42]. However, the direct effector
function of TNF on trypanosomes is only confirmed in a
limited number of T. brucei strains and is not a general
operating mechanism [43].
Part of T. brucei-associated lesions were shown to be
TNF-induced through TNF-R2 activation (CD120b/p75)
[7]. Indeed, in contrast to mouse strains such as C57Bl/6
and C3H/He that show severe inflammatory-associated
pathology during infection, BALB/c and CBA/Ca mice
control inflammation through the shedding of soluble
TNF-R2, which could either interrupt receptor signalling
or block biological activity through the formation of re-
ceptor–ligand complexes [7]. An interesting hypothesis is
that TNF-receptor shedding is controlled by IL-10. As is
shown below, IL-10 has a crucial role in the establishment
of prolonged trypanosome infections.
Finally, in T. evansi models, the role of TNF in para-
sitaemia control and pathology development seems similar
to its role in T. brucei models. Indeed, TNF/ mice show
increased parasitaemia, whereas anaemia is better con-
trolled [29]. Again, a crucial role of TNF-R2 has been
reported here.
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No role for NO in T. brucei control could be established
through knockout mice studies; iNOS/ mice behaved
similarly to fully immune-competent control mice [44–
46]. However, treatment studies using a specific NOS
inhibitor (L-NAME), in addition to one knockout-mice
study, highlighted the role of NO in T. brucei-induced
immunosuppression and anaemia [46–48]. This illustrates
the complementarities of knockout mice and treatment
studies: both differ in the specificity of inhibition and, thus,
in the importance of the redundancy phenomenon, which
refers to the take-over of the removed cytokine or protein
function by present cytokines or proteins.
These data once again stress the difference between the
immune control of the intravascular T. congolense para-
sites and the more systemic control needed in case of T.
brucei or T. evansi infection (Figure 3).
Interferon-g and IL-10: the vital balance
Besides TNF and NO, several additional host immune
factors determine the development of parasitaemia and
infection-associated pathology.
In T. congolense infections, the need for an early inflam-
matory response in efficient parasite control explains the
observed lack of proper parasitemia control and early
death of infected C57Bl/6 interferon (IFN)-g/ mice
[28]. However, results obtained with IL-10/ mice show
that once an effective inflammation has been mounted, an
IL-10-driven response is needed to limit inflammation-
induced lesions [49]. In this regard, IFN-g has been
described as a susceptibility factor in a BALB/c T. con-
golensemodel characterized by early host death, and a link
has been established between early death and unrest-
rained IFN-g production that results in an unbalanced
IFN-g-IL-10 response [26]. T. congolense infections in
IFN-g/ C57Bl/6 and BALB/c mice that were treated with
anti-IFN-g antibodies highlighted these different aspects
of IFN-g involvement as a result of different genetic back-
grounds [25,28,45].
In T. brucei infections, similar IFN-g and IL-10 roles are
described. Indeed, whereas IFN-g/ mice fail to clear
parasitaemia and succumb to uncontrolled parasite
growth, IL-10/ mice control parasitaemia as efficiently
as wild-type mice but succumb because of hyperacute
inflammation after the first parasitemia peak [50]. Hence,
a chronic T. brucei model (phospholipase-C-deleted para-
sites, or PLC/) showed the conversion of an early-stage
IFN-g inflammatory response to a late-stage IL-10-domi-
nated response to coincide with prolonged survival [51].
Combined, these studies point out the central importance
of the IFN-g-to-IL-10 ratio for controllingparasitaemiawith
minimal host damage in both T. congolense and T. brucei
infections. Although scarce, data about the cellular source of
IFN-g and IL-10 seem to be model-dependent. Whereas Shi
et al. [26] showed a role for CD4+ T cells in the secretions of
both cytokines, Namangala et al. [50] showed IFN-g to be
produced mainly by CD8+ T cells and IL-10 to be partially
secreted by CD4+ T cells. These divergences possibly relate
to differences of the parasite or the mouse strain studied.
Recently, the inductionof IL-10-producingregulatoryTcells
in T. congolense infection was also reported to have a major
role in the inhibition of excessive infection-associated
inflammation [52]. However, no regulatory T-cell induction
has been reported in T. brucei infections, despite the crucial
role that IL-10 also has there.
The encephalitic stage of trypanosomiasis: the problem
that kills
As mentioned earlier, trypanosome species such as T.
brucei, T.b. rhodesiense and T.b. gambiense are able to
cross the BBB, causing severe neurological disorders
and risking post-treatment reactive encephalopathy
(PTRE); this has been reviewed recently by others [53–55].
PTRE relates to an exacerbation of the clinical and
pathological features of CNS involvement that is observed
after treatment with an arsenical compound, such as mel-
arsopol, in10% of patients [53]. Inmice, the ‘PTREmodel’
is an infection-treatment model that dynamically reveals
different grades of pathogeny: mild pathogenic CNS inva-
sion, medium-to-severe pathogenic CNS invasion (after
one trypanolytic treatment) and severe PTRE (after a
second treatment) [56]. Analysis of this model has shown
a pivotal role for astrocyte activation, as well as the
importance of endogenous anti-inflammatory cytokines
(IL-10 and IL-6), in the alleviation of neuropathogenesis
during early CNS invasion, and the later involvement of
endogenous TNF in severe cases [56,57]. Other important
factors in this neuropathogenic process were autoanti-
bodies directed against myelin basic protein, myelin-
specific galactocerebrosides and gangliosides, in addition
to substance P (SP), the role of which was highlighted
through in vivo neutralization assays and knockout-mice
studies [58–61]. Again, differences between results
obtained in both types of studies illustrate the difficulties
in addressing the redundancy problem.
Mouse BBB-crossing models have been crucial in
demonstrating the central role of laminin composition of
the basement membrane of the microvascular endothelial
cells, as well as the role of IFN-g in themigration process of
trypanosomes through the BBB [62]. This recent research
involved several knockout mice strains, namely IFN-g/,
IFN-g receptor/, p40 subunit of IL-12/ (IL-12p40/)
and recombinant activating gene-1/ (RAG-1/). In
addition, further treatment studies showed trypanosome
migration to be impeded by Minocyclin, a tetracycline
antibiotic that impedes leucocyte migration in the CNS
in experimental allergic encephalitis [63].
Concluding remarks: where to go from here?
Mouse models have proven to be a valuable tool in un-
derstanding trypanosomiasis susceptibility and pathogen-
esis. This is due to the high variability of phenotypes that
are presented by inbred strains and the powerful investi-
gation tools readily available for murine studies. In the
future, full advantage should be taken of the different
genetic backgrounds in studies using gene deletion, mono-
clonal antibody or cytokine treatment to solve the many
remaining questions that surround trypanosomiasis
pathogenesis and the development of new treatment mod-
alities. Although significant progress has been made in
trypanosome immunopathology research in recent years,
other topics remain poorly understood. Indeed, it remains
to be fully discovered (i) how parasitemia growth control is
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regulated in vivo, (ii) how trypanosomiasis-associated
anaemia is induced, (iii) how the regulation of cytokine
balance occurs throughout infection and (iv) what the
molecular and cellular mechanisms are that underlie the
BBB passage of parasites. These are only a few funda-
mental topics that can be addressed using comparative
studies in different mouse models, supplemented with
studies in gene-deficient mice. These studies combined
should then provide new methods to combat both HAT
and livestock trypanosomiasis (Box 3).
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preponderance of IgM in T. evansi clearance compared to the pivotal role of IgG in T. congolense infection (see text for detailed mechanisms).
Box 3. From mouse to cattle and man?
Undoubtedly, differences occur between long-term murine survival
models and bovine trypanotolerance. Indeed, bovine trypanotoler-
ance (as in the N’Dama breed) consists of efficient parasite control
and reduced lesions, whereas in murine survival models (which are
classically represented by C57Bl/6 mice), parasite clearance is
accompanied by enhanced lesions. However, this must not be
considered as an obstacle to studying trypanotolerance through
mouse models because their advantage interest lies in the high
variability of phenotypes presented by inbred strains. Examples of
successful parallels between murine model breakthroughs and
bovine pathology have been reported in the context of the role of
TNF and for the role of anti-VSG Ig in parasite control. Studies
conducted in knockout mice (see the main text) relate to the finding
in a chimaera bovine-infection model that T. congolense suscept-
ibility and parasitaemia control are regulated independently from
the haematopoietic system [27] and to the reported correlation
between trypanotolerance in livestock and increased specific IgG
production [66,67].
Host genotype influence in HAT is suspected from the wide
variations in disease severity, as recently shown in populations from
Uganda, Zimbabwe and Malawi, reminiscent of earlier propositions
for innate resistance in Bantu populations [68]. Interestingly, trans-
forming growth factor-b involvement inMalawian subtolerance cases
has been suspected, possibly through the limitation of TNF secretion
and, thus, TNF-mediated pathogenesis. A recent study using single
nucleotide polymorphisms in TNF and IL-10 genes and promoter loci
indicates a protective role for a particular IL-10 mutation (IL-10–592a)
in resistance to HAT, whereas a TNF-a-308 promoter mutation
correlated with a higher risk of developing disease early after
exposure [69]. Hence, as in mice, it seems that HAT pathogenesis is
crucially influenced by the balance between TNF and IL-10.
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